Prenosis, Inc.

Prenosis Inc. is a Chicago-based precision medicine and artificial intelligence company founded in 2014, specializing in AI-powered diagnostics for acute care settings. The company's flagship product, the Sepsis ImmunoScore™, is the first FDA De Novo-authorized AI diagnostic tool for sepsis diagnosis and prediction of adverse outcomes. It integrates seamlessly into hospital electronic medical records and provides real-time clinical decision support by combining biomarker analysis with clinical data. The proprietary Immunix® precision medicine platform captures extensive biomarker and clinical data from acute care patients, enabling the development and real-time deployment of precision medicine tools. This platform has built the world's largest biobank linked to clinical infection data in acute care, encompassing over 138,000 longitudinal specimens and 35,000 patients across 11+ hospitals. Prenosis partners with Roche Diagnostics for distribution through the navify® Algorithm Suite. The company empowers clinicians to move beyond symptom-based diagnoses toward biology-based treatment decisions, improving patient outcomes and reducing hospital costs while supporting quality metrics.